US doctors waste millions on branded medicines https://t.co/dgDiJcYUg5 via @FT — The Propell Group (@ThePropellGroup) August 22, 2016 #healthtech
Revenge of the nerds https://t.co/pJXpz2ew2s — The Propell Group (@ThePropellGroup) August 20, 2016 #healthtech
The Economist | The impact on jobs: Automation and anxiety https://t.co/iEZOyKf4ot — The Propell Group (@ThePropellGroup) August 20, 2016 #healthtech
A plan that fails to tackle UK childhood obesity https://t.co/tYSF4ceQWG via @FT — The Propell Group (@ThePropellGroup) August 20, 2016 #healthtech
The Economist | Private share sales: Trading places https://t.co/i6xKQZB3Ai — The Propell Group (@ThePropellGroup) August 19, 2016 #healthtech
The Economist | Rare diseases: Fixing fate https://t.co/rguFWxDDMA — The Propell Group (@ThePropellGroup) August 19, 2016 #healthtech
Adding ages https://t.co/DnLaJSMdvj — The Propell Group (@ThePropellGroup) August 18, 2016 #healthtech
The value of local lessons in tackling global killer diseases https://t.co/pqaZSiHfDl via @FT — The Propell Group (@ThePropellGroup) August 18, 2016 #healthtech
Cheating death https://t.co/qn6eS2mEZJ — The Propell Group (@ThePropellGroup) August 18, 2016 #healthtech
Will embryonic stem cells ever cure anything? https://t.co/0ppYW91aYO — The Propell Group (@ThePropellGroup) August 17, 2016 #healthtech